Kaohsiung Medical University

Yen-Hsu Chen

Hui-Min David Wang

Chung-Yi Chen

Yu-Wei Chang

Chun-Yu Lin

Lih-Geeng Chen

Chin Hsu

Hsin-Ju Chien

Shih-Han Kao

Wan-Chun Huang

Hsi-An Chen

Wei-Ru Lin

Paraskevi Heldin

The present invention discloses a method for treating a subject suffering from a Flavivirus infection. The method includes a step of administering to the subject a pharmaceutical composition including a pharmaceutically effective amount of an anti-CD44 antibody.

Method for treating subject suffering from flavivirus infection

A method of inhibiting the growth of Gram-positive bacteria comprising administering an effective amount of Tellimagrandin II, its pharmaceutically acceptable salt, enantiomer, isomer or tautomer to a subject is provided. The Gram-positive bacteria comprise methicillin-resistant. A method of treating sepsis comprising administering an effective amount of Tellimagrandin II, its pharmaceutically acceptable salt, enantiomer, isomer or tautomer to a subject is also provided. A method of treating leukemia comprising administering an effective amount of Tellimagrandin II, its pharmaceutically acceptable salt, enantiomer, isomer or tautomer to a subject is further provided.

Anti-bacterial infection, inflammation, and leukemia composition and use thereof

A method for improving tetracycline-resistance of, by providing a ginger compound combined with tetracycline to againstinfection, wherein the ginger compound comprises [6]-dehydrogingerdione, [6]-shogaol and [6]-gingerol or [10]-gingerol, [6]-shogaol and [6]-gingerol.

[object Object]

Growing community of inventors

Kaohsiung, Taiwan

Yen-Hsu Chen